Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
Deregulation of transcription factors is frequently observed in cancer. Here, the authors develop a blood-based approach to map transcription factor binding, revealing both patient-specific and tumour-specific aberrations
Guardado en:
Autores principales: | Peter Ulz, Samantha Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E. S. Roberts, John St. John, Michael G. Schimek, Jochen B. Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer, Michael R. Speicher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbef1e4364b449e490e94bf709b557cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
por: Peter Ulz, et al.
Publicado: (2020) -
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
por: Sumitra Mohan, et al.
Publicado: (2014) -
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
por: Peter Ulz, et al.
Publicado: (2016) -
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
por: Michael Stotz, et al.
Publicado: (2014) -
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
por: Joanna Szkandera, et al.
Publicado: (2013)